1.Alternative Name:ERBB1, HER1
2.Target:EGFR
3.Source:Human EGFR was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Leu25-Ser645
5.Protein structure:P00533His
6.Molecular Characterization:The protein has a calculated MW of 69kDa.The reducing (R) heterodimer protein migrates as 90-130 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human EGFR/His Protein（WT）is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human EGFR(Cetuximab) that produces 50% of the optimal binding response is approximately 13 ng/ml.

Note:For research use only .